Showing results (381-390 of 445) with videos related to

Sort By:
Pageof 45
International Journal of Molecular Sciences|February 27, 2026
Estrogen Signaling During Abrupt Involution and Long-Term Metabolic Signature Similar to Estrogen Receptor-Negative Breast CancerKate Ormiston, Neelam Shinde, Gautam Sarathy, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 7, 2011
Long-term benefit of the TAXUS Liberté stent in small vessels and long lesions. TAXUS ATLAS programJohn A Ormiston, Mark A Turco, Jack J Hall, et al.
Circulation. Cardiovascular Interventions|November 11, 2010
Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesionsJohn A Ormiston, Alexandre Abizaid, John Spertus, et al.
Nature Medicine|June 16, 2015
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertensionLu Long, Mark L Ormiston, Xudong Yang, et al.
Journal of the American College of Cardiology|April 24, 2007
Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trialMark A Turco, John A Ormiston, Jeffrey J Popma, et al.
The International Journal of Cardiovascular Imaging|November 24, 2011
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldSalvatore Brugaletta, Josep Gomez-Lara, Hector M Garcia-Garcia, et al.
American Journal of Respiratory and Critical Care Medicine|August 27, 2015
Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with SchistosomiasisAlexi Crosby, Elaine Soon, Frances M Jones, et al.
Lancet (London, England)|September 5, 1998
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)P W Serruys, B van Hout, H Bonnier, et al.
Circulation|July 27, 2012
Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertensionMark L Ormiston, Chiwen Chang, Lu L Long, et al.
European Heart Journal|April 18, 2012
Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?Salvatore Brugaletta, Jung Ho Heo, Hector M Garcia-Garcia, et al.
Pageof 45